title: Commentary: controversies in NICE guidance on prostate cancer.
authors.affiliation: Minneapolis VA Center for Chronic Disease Outcomes Research, 1 Veterans Drive (111-0), Minneapolis, MN 55417, USA. Tim.wilt@med.va.gov
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Wilt
mesh_terms: D020811:Biomedical Technology; D004059:Diffusion of Innovation; D006296:Health Services; D006801:Humans; D008297:Male; D054526:Men's Health; D017410:Practice Guidelines as Topic; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D017430:Prostate-Specific Antigen